U n i v e r s i t i e s of Wiirzburg and Ulm, FRG. ECTOPIC A~H SYNDROME AND "TUMOR HYPERCALCEMIA" DUE TO A MEPATOBLASTOMA. We a r e reporting t h e f i r s t c a s e of combined ectopic ACTH syndrome and "humoral hypercalcemia of malignancy" i n a c h i l d with a l i v e r tumor: A 6 9/12 y o g i r l presented with Cushlng's syndrome, hypercalcemla and a l a r g e l i v e r tumor. Serum CRF was und e t e c t a b l e . ACTH ranged from 184 to 819 ~/ m l and was unrespons i v e t o CRF and dexamethasone ( 2 and 8 mg). A l l urinary s t e r oi d s , except f o r THAldo, were g r e a t l y elevated. By c o n t r a s t , serum m u l t i s t e r o i d a n a l y s i s revealed high l e v e l s of only c o r t i s o l , c o r t i c o s t e r o n e and DHAS, whereas p r q e s t i n s (Prog, 17-OHProg) and mineralocorticoids (DOC, Aldo) were normal. Serum Ca was 14.2 mg/dl, P 2.2 mg/dl, 1.25-(OH) D 61 pq/ml (normal: 20-40), urinary cAMP 6.7 nmol/dl GF (normal : ? .6-4.9 ) and P reabsorption 1 .6 mg/dl (normal: 4.5-6.8). Serum PTH(44-681, 25-(OHID, AP, osteoc a l c i n and u r i n a r y Pro-OH were normal, and PTli(intact) was suppressed, suggesting t h e presence of a PTH-like f a c t o r d i s t i n c t from PTR. The tumor was s u r g i c a l l y removed and proved t o be a hepatoblastoma. Extraction yielded 8.3 ng/gm of ACTH and 0
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INTACT PTH LEVELS IN HEALTHY TERM NEONATES (HTN) AND IN EARLY NEONATAL HYPOCALCEMIA ( E N H )
. W e employed a new IRMA i n t a c t P7H assay (Allegro, Nichols I n s t i t u t e ) , which i s able t o detect t h e biologically active form of t h e hormone, in order t o evaluate the secretory patterri of PTH i n norn~al newhorns and i n preterm i n f a n t s with ENH. Intact PTH l e v e l s were low in cord serum ( n . v . in chidren 38.0 1 12.5 pg/ml) i n both HTN and in ENH. In HTN we found a s i g n i f i c a n t r i s e of PTH l e v e l s w i t t a peak a t day l o (+7.5 f o l d ) and a s l i g h t f a l l a t day 5" ( T a b l e ) . In ENtI i n t a c t PTH values increased more (t1Sr f o l d ) than in HTN i~nd showed a decrease when normal calciun~ l e v e l s were achieved ( T a b l e ) . Values as mean 2 1SD.Osignificantly d i f f e r e n t frc:m b i r t h (pcO.OOl);*significantly d i f f e r e n t frcm b i r t h and HTN (pe0.001). Our data showed t h a t in ENH i n t a c t PTH levels rose in f i r s t hours of l i f e when calcium decrease as in HTN demonstrating a normal responsiveness cf parathyroid g1anc:s t o hypocalcemia alsc; i n pretern~ i n f a n t s .
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GLUCOSE INTOLERANCE IN CYSTIC FIEROSIS (CF).
Up t o 60% of children with CF develop glucose intolerance (GI). Many CF p a t i e n t s maintain a normal glucose tolerance (NGT) with a low i n s u l i n e response during the oral glucose tolerance t e s t (OGTT). . .
W e studied 48 CF p t s . (aged 2-29 y e a r s ) without c l i n i c a l manif e s t a t i o n s of diabetes m e l l i t u s . Assessment included OGTT, hemoglobin A~c , a n t i -i s l e t antibodies, pulmonary s t a t u s and l i v e r involvement. The OGTT was considered abnormal when t h e 2h serum glucose level was higher than 140 mg/dl. There was no s i g n i f icant difference between the 15 p t s . with and the 33 pts.without GI i n terms of mean age, wheight index, degree of lung and l i v e r involvement.
Fasting i n s u l i n ( i n s . ) , peak i n s . response, max. ins./max. glucose r a t i o , and area under the ins.response curve were not d i f f e r e n t in GI and NGT group. Peak glucose and peak i n s . response were s i g n i f i c a n t l y delayed in GI vs NGT p t s . (99 n~in and 117 min vs 55 min and 86 min) and Hb A~c . was higher in t h e former (8,2% vs 7,5%) . No c i r c u l a t i n g a n t i -i s l e t antibodies were detected in e i t h e r group.
In conclusion, CF p a t i e n t s with GI d i f f e r from those with NGT by a delayed glucose and i n s u l i n e response t o OGTT. S e r i a l Hb AIC l e v e l s car1 be used as a simple and r e l i a b l e method f o r t h e prediction of GI i n CF. In human placenta, adenylate cyclase i s a c t i v a t e d by hormones l i k e human c h o r i o n~c gonadotropin, epinephrine, prostaglandins, l u t e i n i z i n g hormone and v a s o i n t e s t i n a l polypeptide. For t h e l i v e r , t h e r e s u l t a n t second messenger adenosine 2 ' : 3 ' -c y c l i c monophosphate (CAMP) i s known t o induce phosphoenol-pyruvate carboxykinase (PEP-CK). So f a r t h e r e have bccn no r e p o r t s concerning p l a c e n t a l PEP-CK. -METHODS: 600 mg t i s s u e of human term placentae was incubated i n E a r l e ' s s o l u t i o n and amino a c i d s by gassing with 0 2 and C 0 2 f o r 120 minutes. Dhutyryl-CAMP w a s added t o a f i n a l concentration of 1 mM. PEP-CK and the o t h e r l mp o r t a n t gluconeogenlc enzyme pyruvate carboxylasc (PC) were determined i n p l a c e n t a l t i s s u e by 1 4~0 2 f i x a t i o n method. -RESULTS: 1. The incubation elevated PC a c t i v i t y from 32.9 2 15.9 uU/mg p r o t e l n (mean + S.D.) p o s t partum t o 81.6 5 30.8 (n=6; pC0.05) and PEP-CK from 8.65 + 4.0 t o 233.6 + 88.8 (n=5; pC0.05).
2 . Dibutyryl-CAMP had no e f f e c t on PC (74.9 + 19.6; n=6) , b u t lowered PEP-CK t o 59.1 24.3 (n=5; p<0.05). -CONCLUSIONS: 1 . Placental PC 1s not sub]cctecl t o hormonal regulation which i s m e d~a t e d by CAMP. 2 . PEP-CK l n placenta showed a p a t t e r n different from t h e l i v e r : cAMP deinduced PEP-CK. Thls observat i o n LS i n accordance w i t h our previous findings of epinephrlne a c t i o n on placenta (1.Henrichs e t a l . , Acta endocrin. 114, 36-37 (1987) ). DISORDERS AND SENSORY POLYNEUROPATHY Idiopatilic absorptive hypercalciuria ( t i l l ) Inlay be due t o dn i n t e s t i n a l i~y p e r s e n s i t i v i t y t o norl~lal I,L5(Uli)Vit U l e v e l s or a prilnary i n t e s t i n a l hyperabsoption of c a l c i u~~~. ltecent study showed t h a t t h e antiiriycotic agent ketoconazole induce i n h i b i t i o~i of I-alpha-hydroxylase.
To detect the r o l e of l.Z!)(Uli)Vit U i n the genesis of AH we tested the e f f e c t s of ketoconazole ( K ) ( 3 nlglKgldaily in three doses f o r a week) on 1,25(OH)Vit U l e v e l s (n.v. 3tj.2 t 7.5 pg/nil) and 24 hours urinary calciurii excretiori (24h UCa) 6 v . c 4 n~g/Kg/daily) in a child ( W , 5 y r s ) with diagnosed AH. Results were as follows: before K: 1,25(OH)Vit i): 61.6, 24h UCa 10.8; 6 days a f t e r K: 1,25(OH)Vit 0 40.7 ( -34 d l , 24h UCa: 3.8 ( -65 P); 2 days a f t e r suspension of K : 1,25(0H)Vit D: 50.2; 24h UCa: 13.7. There was no e f f e c t of K on seruiu l e v e l s of \.lid-1401 PTH, 25-OH-U, calciuiiu, phosphate, ~n~agnesiun~ and a l k a l i n e phosphatase. The concormlitant reduction of 1,25(UH)Vit U and ;!4h UCe a f t e r 6 days of K suggests t h a t in AH may Ibe present an i n t e s t i n a l hyl)erresponsiveness t o 1,25(OH)Vi t U . This data iiypothizes a possible therapy with K in AH. Further s t u d i e s a r e needed i n other cases.
A 10 year o l d boy is described with a syndrome o f adrenal i n s u f f i c i e n c y due t o s e l e c t i v e ACTH insensitivity associated with autonomic nervous system d i s o r d e r s and sensory polyneuropathy. Production of glucocorticoids and adrenal androgens were i n s u f f i c i e n t , but t h e r e were no s i g n s o f even l a t e n t mineraloc o r t i c o i d i n s u f f i c i e n c y ( a f t e r 4 days o f low sodium diet-9mEqIL NaCl/day). I n a d d i t i o n t o a c h a l a s i a , d e f e c t i v e lacrimation, anisocoria and hyperkeratosis of palrnes and soles,we a l s o found d e f e c t i v e sweating, permanent c u t l s anserina (impaired function o f smooth h a i r muscles) and electromyographically proved sensory polyneuropathy, which were not previously reported i n t h i s r a r e syndrome.
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